Related Experiment Video
Updated: Mar 31, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Agentic AI for Prostate Cancer: A Vision for Multimodal Clinical Intelligence
N Papanikolaou1, A R Padhani2, F Sanguedolce3
1Clinical Computational Imaging Group, Champalimaud Research, Lisbon, Portugal.
Abstract:
While artificial intelligence (AI) is rapidly advancing in prostate cancer diagnostics and therapy planning, its impact on everyday clinical decision-making remains marginal. To fill this gap, "Agentic AI systems" are under development: working at an orchestration layer integrating the different AI agents, they are proposed as a powerful tool to synthesize the different clinical information, supporting clinicians' decision-making more effectively.

